RESULTS: A significant improvement of 60% in the IVRgroupfor the primary composite outcome was found (RR1.60, 95% CI: 1.29 to 2.00, p < 0.001). There was significant improvement in medication compliance (p < 0.001) and decrease in unplanned medical visits (p = 0.023). At one year, the majority of @entity1 (85%) responded positively to using the system again. Follow-up by IVR produced positive outcomes in @entity1187 @entity1 . BACKGROUND: There is evidence from large clinical trials that compliance with standardized best practice guidelines (BPGs) improves survival of @entity1187 ( @entity1187 ) @entity1 . However, their application is often suboptimal. PURPOSE: In this study, the researchers evaluated whether the use of an interactive voice response (IVR) follow-up system improved @entity1187 BPG compliance. METHOD: This was a single-centre randomized control trial (RCT) of 1,608 @entity1 (IVR=803; usual care=805). The IVR group received five automated calls in 12 months. The primary composite outcome was increased medication compliance and decreased adverse events.

Using interactive voice response to improve disease management and compliance with XXXX best practice guidelines: A randomized controlled trial.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1187 :: ('MESH:D054058', 'Disease') :: ['ACS', 'acute coronary syndrome']
@entity1187 :: (MESH:D054058,Disease) :: ['acute coronary syndrome']
